• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,092
79
60
57
46

COUNTRY

55
19
8
6
5

CATEGORIES

  • 89
  • 128
  • 71
  • 72
  • 44
  • 43
  • 21
  • 16
  • 20
  • 22

PRICE

550
801
1,599
2,561

PUBLISHED

145
296
750
2,561

PRODUCT TYPE

2,413
74
61
12
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Triple Analysis: Lymphoma, Melanoma and Apoptosis Triple Analysis: Lymphoma, Melanoma and Apoptosis - Product Thumbnail Image

Triple Analysis: Lymphoma, Melanoma and Apoptosis

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Apoptosis. Each of these three individual parts is evaluated according...

June 2013
FROM
Triple Analysis: Melanoma, Pancreatic Cancer and Antibodies Triple Analysis: Melanoma, Pancreatic Cancer and Antibodies - Product Thumbnail Image

Triple Analysis: Melanoma, Pancreatic Cancer and Antibodies

This triple analysis focuses on cancer drug development strategies in both Melanoma and Pancreatic Cancer and by the compound strategy of Antibodies. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Melanoma, Apoptosis and Antibodies Triple Analysis: Melanoma, Apoptosis and Antibodies - Product Thumbnail Image

Triple Analysis: Melanoma, Apoptosis and Antibodies

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Apoptosis) and one compound specific area (Antibodies)....

June 2013
FROM
Triple Analysis: Breast Cancer, Colorectal Cancer and Melanoma Triple Analysis: Breast Cancer, Colorectal Cancer and Melanoma - Product Thumbnail Image

Triple Analysis: Breast Cancer, Colorectal Cancer and Melanoma

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Colorectal Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria...

June 2013
FROM
Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria...

June 2013
FROM
Triple Analysis: Breast Cancer, Melanoma and Angiogenesis Triple Analysis: Breast Cancer, Melanoma and Angiogenesis - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Angiogenesis

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Colorectal Cancer, Melanoma and Angiogenesis Triple Analysis: Colorectal Cancer, Melanoma and Angiogenesis - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Melanoma and Angiogenesis

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is...

June 2013
FROM
Triple Analysis: Colorectal Cancer, Melanoma and Protein Kinase Inhibitors Triple Analysis: Colorectal Cancer, Melanoma and Protein Kinase Inhibitors - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Melanoma and Protein Kinase Inhibitors

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual...

June 2013
FROM
Triple Analysis: Leukemia, Lung Cancer and Melanoma Triple Analysis: Leukemia, Lung Cancer and Melanoma - Product Thumbnail Image

Triple Analysis: Leukemia, Lung Cancer and Melanoma

This triple analysis focuses on cancer drug development strategies in Leukemia, Lung Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five...

June 2013
FROM
Triple Analysis: Leukemia, Melanoma and Protein Kinase Inhibitors Triple Analysis: Leukemia, Melanoma and Protein Kinase Inhibitors - Product Thumbnail Image

Triple Analysis: Leukemia, Melanoma and Protein Kinase Inhibitors

This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts...

June 2013
FROM
Triple Analysis: Leukemia, Melanoma and Peptides Triple Analysis: Leukemia, Melanoma and Peptides - Product Thumbnail Image

Triple Analysis: Leukemia, Melanoma and Peptides

This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according...

June 2013
FROM
Triple Analysis: Lung Cancer, Melanoma and Angiogenesis Triple Analysis: Lung Cancer, Melanoma and Angiogenesis - Product Thumbnail Image

Triple Analysis: Lung Cancer, Melanoma and Angiogenesis

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Lung Cancer, Melanoma and Protein Kinase Inhibitors Triple Analysis: Lung Cancer, Melanoma and Protein Kinase Inhibitors - Product Thumbnail Image

Triple Analysis: Lung Cancer, Melanoma and Protein Kinase Inhibitors

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts...

June 2013
FROM
Triple Analysis: Lymphoma, Melanoma and Prostate Cancer Triple Analysis: Lymphoma, Melanoma and Prostate Cancer - Product Thumbnail Image

Triple Analysis: Lymphoma, Melanoma and Prostate Cancer

This triple analysis focuses on cancer drug development strategies in Lymphoma, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in...

June 2013
FROM
Triple Analysis: Lymphoma, Melanoma and Angiogenesis Triple Analysis: Lymphoma, Melanoma and Angiogenesis - Product Thumbnail Image

Triple Analysis: Lymphoma, Melanoma and Angiogenesis

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated...

June 2013
FROM
Triple Analysis: Breast Cancer, Leukemia and Melanoma Triple Analysis: Breast Cancer, Leukemia and Melanoma - Product Thumbnail Image

Triple Analysis: Breast Cancer, Leukemia and Melanoma

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Leukemia and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a...

June 2013
FROM
Triple Analysis: Breast Cancer, Lymphoma and Melanoma Triple Analysis: Breast Cancer, Lymphoma and Melanoma - Product Thumbnail Image

Triple Analysis: Breast Cancer, Lymphoma and Melanoma

This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lymphoma and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a...

June 2013
FROM
Triple Analysis: Breast Cancer, Melanoma and Antibodies Triple Analysis: Breast Cancer, Melanoma and Antibodies - Product Thumbnail Image

Triple Analysis: Breast Cancer, Melanoma and Antibodies

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated according...

June 2013
FROM
Triple Analysis: Colorectal Cancer, Lymphoma and Melanoma Triple Analysis: Colorectal Cancer, Lymphoma and Melanoma - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Lymphoma and Melanoma

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Lymphoma and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in...

June 2013
FROM
Triple Analysis: Colorectal Cancer, Melanoma and Antibodies Triple Analysis: Colorectal Cancer, Melanoma and Antibodies - Product Thumbnail Image

Triple Analysis: Colorectal Cancer, Melanoma and Antibodies

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the compound strategy of Antibodies. Each of these three individual parts is evaluated...

June 2013
FROM
Loading Indicator

Our Clients

Our clients' logos